Allison Rhines

As Head of Johnson & Johnson Innovation – JLABS @ TMC, Dr. Rhines leads the JLABS @ TMC team in incubating and growing the JLABS community of companies, as well as in enabling strategic partnerships between JLABS companies and the broader ecosystem. Prior to this role, Dr. Rhines served as Early Innovation Partnering Lead for Infectious Disease, Vaccines, and Global Public Health within Johnson & Johnson Innovation, based in the San Francisco Innovation Center. She re-joined J&J in this role from the Gates Foundation’s early innovation organization, now known as the Gates Biotech Accelerator. There, she managed the Foundation’s SARS-CoV-2 transmission biology portfolio at the onset of the pandemic, followed by diverse biopharma investments in early-stage platform technologies. Prior to joining the Gates Foundation, Dr. Rhines held various venture-backed startup operating responsibilities. Dr. Rhines completed her postdoctoral fellowship within Johnson & Johnson’s Global Public Health group. She holds her PhD in Biology with a mathematical and computational focus, as well as her BA, from Stanford University. She holds her MBA from INSEAD and her MPhil from the University of Cambridge.